Oxytocin 10mg

Researchers evaluating where to buy Oxytocin for research need a documentation-led review, not a consumer-facing product narrative. Oxytocin is a cyclic nine-amino-acid peptide with the sequence CYIQNCPLG and a documented molecular identity in major pharmacology and chemistry databases [1] [2]. This Pure Lab Peptides guide keeps the focus on research-use-only positioning, COA review, analytical testing, lot traceability, and careful interpretation of published literature.

• Oxytocin is a hormone and neuropeptide research compound with a cyclic nonapeptide structure and a reported molecular formula of C43H66N12O12S2 [1] [2].
• The oxytocin receptor is classified in the vasopressin and oxytocin receptor family and is documented as a class A G protein-coupled receptor in pharmacology databases [3] [4].
• Research buyers should evaluate COA availability, identity data, purity testing, lot number alignment, and RUO labeling before procurement.
• Published literature can provide compound, receptor, pathway, and model-specific context, but it should not be converted into product claims.
• Documentation matters because purity, identity, storage records, and batch-specific files help laboratory teams organize research materials consistently.

Fast Answer: What Should Researchers Check Before They Buy Oxytocin for Research?

Researchers should evaluate the documentation, COA, identity testing, purity data, lot traceability, and RUO label before they buy Oxytocin for research. Products discussed in this article are intended for laboratory research use only and are not intended for human or animal consumption. The most useful commercial research review compares the product listing against batch-specific records and analytical method details.

Before procurement, check whether the label matches the COA, whether the lot number is visible, and whether analytical testing supports the stated compound identity.

What Documentation Should Come First?

The first review point is the batch-specific COA. Analytical validation frameworks emphasize that procedures should be suitable for the attribute being measured, including identity, purity, and related quality characteristics in appropriate analytical contexts [7] [8].

For an Oxytocin research material, the COA should be read alongside the label, product listing, lot number, storage notation, and any available method records. No single document should carry the full review by itself.

Why Does RUO Labeling Matter Before Procurement?

RUO labeling tells the reader that the material belongs in a laboratory research context. U.S. labeling rules for certain laboratory research-phase products include a prominent research-use-only statement, and FDA guidance stresses that RUO labeling must align with how a product is represented [9] [10].

The goal is clarity before any purchasing decision.

What Is Oxytocin in Research Literature?

Oxytocin is a peptide hormone and neuropeptide that appears across endocrine, receptor-signaling, neurobiology, and analytical chemistry literature. The IUPHAR/BPS Guide to Pharmacology lists oxytocin as an endogenous peptide ligand, while ChEMBL reports its molecular formula and molecular weight for compound identity reference [1] [2].

What Defines Oxytocin as a Neuropeptide Research Compound?

Oxytocin is commonly described as a cyclic nonapeptide. IUPHAR lists the peptide sequence as CYIQNCPLG and notes a disulfide bond between cysteine residues at positions 1 and 6 with C-terminal amidation [1].

That structural identity is why sequence, molecular weight, and method records matter for research procurement.

How Is Peptide Hormone Identity Documented?

Peptide hormone identity can be documented through compound database records, sequence references, COA data, and analytical method outputs. NCBI describes the OXT gene as encoding a precursor that is processed to oxytocin and neurophysin I [5].

For procurement teams, the practical task is to compare the compound name, sequence, molecular weight, and lot-specific documentation. If those records do not align, the material needs additional review before it enters a laboratory inventory.

Where Do Hypothalamus and Pituitary Contexts Belong?

NCBI’s OXT gene record describes oxytocin as associated with a precursor system connected to hypothalamic synthesis and posterior pituitary context [5].

Published reviews also discuss oxytocin in relation to parturition, lactation, receptor signaling, and central research models [11] [12].

Scientific Background Within RUO Scope

Scientific background helps researchers understand why Oxytocin appears in neuropeptide literature, but it does not establish the suitability of this supplied material for non-research use.

Oxytocin Receptor Context in Published Literature

The oxytocin receptor is listed by IUPHAR as an OT receptor in the vasopressin and oxytocin receptor family, with human OXTR documented as a class A GPCR [3]. UniProt describes OXTR activity as G protein-mediated and linked to a phosphatidylinositol-calcium second-messenger system [4].

NCBI also describes OXTR as encoding a G protein-coupled receptor for oxytocin [6]. These records support receptor-pathway context, not product claims.

Central Signaling Models and Research Interpretation

Neuropeptide research often examines how peptide signaling interacts with broader neural circuit models. Russo’s review notes that neuropeptides can modulate co-released neurotransmitter activity in the brain and periphery [13].

Oxytocin-specific reviews discuss receptor distribution, central signaling models, and circuit-level questions in academic contexts [14] [15].

What Does Physiological Background Tell Researchers?

The literature describes oxytocin’s established physiological background in uterine contraction, childbirth-associated endocrine literature, lactation, and milk let-down contexts [11] [12]. Those topics help explain why the compound is widely studied, but they do not define any intended context for an RUO research material.

This guide provides scientific background, not clinical, personal, or consumer-use guidance.

How Does Published Literature Frame Oxytocin Research?

Published Oxytocin literature spans compound identity, receptor biology, endocrine physiology, neurobiology, and model-specific signaling. Reviews by Gimpl and Fahrenholz, Jurek and Neumann, and Lee and colleagues each describe different aspects of the oxytocin system [11] [12] [16].

Published literature provides research context. It is not a substitute for batch-specific documentation of the material under review.

What Can Preclinical Literature Support?

Preclinical literature can support questions about model design, receptor expression, signaling hypotheses, and pathway mapping. Jurek and Neumann review OXT expression, OXTR binding, and OXTR-coupled signaling across research contexts [16].

Other reviews discuss oxytocin pathways and sensory-system interactions in model-specific academic literature [17]. That evidence should stay tied to study design and model limitations.

Where Do In Vitro Models Fit the Evidence Map?

In vitro models can help researchers examine receptor signaling, ligand interaction, and pathway readouts under controlled conditions. Chatterjee and colleagues compiled oxytocin-OXTR signaling reactions from literature to organize the receptor signaling network [18].

Cell-based receptor responsiveness studies can also examine signaling features such as phospholipase C activity and calcium-related readouts under defined assay conditions [19]. Those models are useful for research interpretation, not product positioning.

Why Does Study Design Matter for Interpretation?

Study design determines what a paper can and cannot support. A receptor assay, a preclinical model, an analytical chemistry paper, and a literature review answer different questions.

For procurement teams, that distinction matters. Literature can explain why a compound is studied, while COA and analytical records explain what the supplied research material is documented to be.

Evidence Interpretation Framework for Oxytocin Research Buyers

An evidence interpretation framework helps prevent over-reading. It separates compound facts, receptor context, model-specific findings, analytical verification, and RUO labeling.

How Does Source Quality Shape Research Confidence?

Source quality starts with official databases, peer-reviewed reviews, and primary analytical literature. Recent reviews can help summarize a large evidence base, but databases are often better for fixed identity details such as receptor names, sequence references, and molecular records [1] [2] [3] [22].

Mixing those two roles creates avoidable risk.

What Translational Limits Should Be Flagged?

Some published literature outside the scope of RUO product use has examined this compound class in human study settings. That literature should not be interpreted as a use claim for research-use-only materials.

COA Documentation for Oxytocin Research Procurement

A COA is one of the most important documents for Oxytocin research procurement. It should help the reviewer connect a product listing to a specific batch and its supporting analytical records.

A useful COA does not stand alone. It should match the label, lot number, product page, and supporting supplier documentation.

What Should a Certificate of Analysis Show?

A certificate of analysis should identify the material, lot number, test date or report date, reported purity, testing method, and supplier or laboratory record. FDA analytical-method guidance describes how method validation data can support documentation of identity, quality, purity, and related attributes in regulated analytical contexts [8].

ICH Q2(R2) also provides a framework for evaluating validation characteristics for analytical procedures [7]. For RUO procurement, this reference helps laboratory teams understand why method detail is important.

Why Do COA Dates and Lot Numbers Matter?

COA dates and lot numbers help connect a report to a specific batch. Without that connection, a buyer cannot easily tell whether the analytical record belongs to the material under review.

Lot-level alignment is also a traceability practice. NIST describes metrological traceability as a documented connection between measurement results and specified references through an unbroken chain of comparisons [23].

Purity and Identity Testing for Oxytocin

Purity and identity are related, but they are not the same review point. A purity result can describe the proportion of a main chromatographic peak under a method, while identity testing asks whether the material corresponds to the expected compound.

For Oxytocin, a stronger documentation file includes both purity and identity support.

How Does HPLC Support Peptide Purity Review?

HPLC is widely used for peptide separation and purification because different modes can separate peptides by properties such as hydrophobicity, charge, or size [20]. USP <621> provides general chromatography terminology, definitions, calculations, and system suitability concepts for chromatographic procedures [24].

For procurement review, an HPLC chromatogram can support purity review when it is connected to the correct batch and method conditions. It should not be treated as complete identity proof by itself.

How Does LC-MS Support Identity Verification?

LC-MS combines chromatographic separation with mass spectrometric detection. LC-MS literature notes that high-resolution systems can identify peptides using accurate mass measurements and elution behavior [21].

Peptide-focused LC-HRMS work has also been used to characterize peptide materials and related impurities [25]. For short peptides, LC-MS identity work may require careful attention to homologous or closely related structures [26].

Analytical Verification Workflow Before Research Procurement

This verification sequence covers records, labels, and analytical outputs. It does not provide product-preparation instructions.

1. Verify that the compound name, lot number, and RUO label match across the product listing and supplier documents.
2. Review the batch-specific COA.
3. Check whether the purity method is listed.
4. Confirm whether identity testing is supported by LC-MS or another suitable analytical method [21] [25].
5. Review chromatogram or mass data when available [20] [24].
6. Check the COA date and laboratory source.
7. Record storage and handling notes in the laboratory file.
8. Save the product listing, COA, and batch documents together for procurement review.

Chromatogram Review and Retention-Time Consistency

A chromatogram can help reviewers assess separation behavior, peak profile, and method consistency. USP <621> discusses chromatographic definitions and system suitability concepts that help frame this type of review [24].

Retention-time consistency is most useful when the method, reference data, and batch record are available together. Without that context, a chromatogram is only a partial documentation signal.

Testing Records for Supplier Evaluation

Supplier evaluation should look at whether testing records are batch-specific, method-aware, and internally consistent. ICH Q14 describes science- and risk-based approaches for analytical procedure development, while ISO/IEC 17025 focuses on laboratory competence and the generation of valid testing and calibration results [27] [28].

For a research buyer, that means the documentation file should show more than a number. It should show how that number fits the material being reviewed.

Lot Traceability and Batch Documentation Review

Lot traceability connects the product listing, COA, label, and supplier file. It is a procurement control, not a product claim.

When traceability is weak, the buyer may not be able to confirm whether the documentation belongs to the material being evaluated.

What Does Lot Traceability Add to Procurement Review?

Lot traceability adds continuity. It links the listed research material with the corresponding batch-specific record, date, and analytical data.

NIST’s traceability policy explains the value of documented measurement connections, while ISO/IEC 17025 emphasizes competent laboratory operation and valid results [23] [28]. Those principles support careful review of lot-level documentation.

Batch Records for Reproducibility Planning

Batch records help laboratory teams organize future procurement decisions.

For Oxytocin research materials, batch records should be saved with the COA, chromatogram, identity file, storage notes, and product-page snapshot. This keeps the procurement file coherent.

Storage, Handling, and Labeling Documentation

Storage, handling, and labeling documentation help laboratory teams maintain a clear chain of records after procurement.

How Do Storage Notes Support Material Integrity?

Storage notes support material integrity by giving laboratory teams a documented condition to record and follow within their institutional system. The key point is consistency between the product page, label, COA, and any supplemental supplier record.

Storage information should be treated as a documentation item.

Handling and Chain-of-Custody Records

For laboratory recordkeeping, review labeling, documented storage conditions, and chain-of-custody records. These records do not establish suitability for personal, clinical, or consumer use.

Supplier Documentation Checklist for Oxytocin Research Procurement

A practical checklist helps research buyers compare Oxytocin suppliers without relying on marketing language.

• Verify that the product is labeled for research use only.
• Review the batch-specific certificate of analysis.
• Confirm that purity data are supported by analytical testing.
• Check that the lot number on the COA matches the product documentation.
• Compare compound name, molecular weight, and sequence across documentation.
• Assess whether the product page avoids consumer-facing and claim-heavy language.
• Document storage and handling conditions in a laboratory record.
• Save the product listing, COA, label information, and batch file together.

What Should Researchers Compare Across Supplier Documentation?

Researchers should compare the listing, label, COA, lot number, method notation, and storage notes. The documents should tell the same story.

If the name, lot number, or method details are inconsistent, the file should be reviewed before procurement. A research buyer should not rely on isolated claims.

Labeling Consistency Across Product Listings

Labeling consistency helps reduce confusion across product pages, invoices, COA files, and stored records. The compound name, RUO status, and lot information should remain consistent.

Common Misunderstandings in Oxytocin Research Procurement

• Published literature does not equal product positioning.
• Preclinical findings should not be converted into product claims.
• A purity percentage does not prove complete compound identity; HPLC and LC-MS support different parts of the review [20] [21].
• A COA should be batch-specific and tied to a visible lot number.
• RUO labeling does not support consumer or clinical positioning [9] [10].
• Pathway relevance does not equal a supplied product claim.
• Catalog specifications are listing details, not research conclusions.

Next-Step Documentation Review for Research Procurement

A final documentation review should happen before the purchase decision. This review is not about product outcomes; it is about whether the research material has a coherent file.

The strongest procurement file includes the product listing, RUO label, COA, lot number, method details, purity record, identity record, storage notes, and supplier documentation.

What Should Researchers Save Before They Buy Oxytocin for Research?

Before researchers buy Oxytocin for research, they should save the product-page record, batch-specific COA, lot number, analytical testing files, and storage documentation. This gives the lab a consistent procurement file.

The saved file should also include the date of review. That makes later recordkeeping easier if product documentation changes.

Documentation Review Signals for Lab Purchasing Teams

Lab purchasing teams should look for transparent labeling, batch-specific records, method clarity, and clear separation between literature context and product positioning. These signals are more useful than broad claims.

A careful review also checks what the page avoids. Clean RUO pages avoid wellness framing, consumer outcomes, clinical positioning, and unsupported claims.

Next Steps

Review the product-page documentation, COA details, analytical testing records, and RUO labeling before evaluating this compound for laboratory research. For research teams comparing peptide suppliers, prioritize transparent labeling, batch-specific documentation, and lot-level traceability.

FAQs

What does research use only mean for Oxytocin?

Research use only means Oxytocin is supplied solely as a laboratory research material. It is not intended for human or animal consumption or any consumer-facing purpose. Procurement review includes compound identity, research documentation, the COA, analytical testing, lot traceability, and supplier records.

What should researchers consider before they buy Oxytocin for research?

Researchers should consider documentation first before they buy Oxytocin for research. The key review points include RUO labeling, a batch-specific COA, lot traceability, analytical testing records, and consistency between the product listing and supplier documentation.

What is Oxytocin in research literature?

Oxytocin is described in research literature as a cyclic peptide hormone and neuropeptide with a documented compound identity [1] [2]. Literature background does not establish an intended use for the supplied research material beyond laboratory research.

How does mass spectrometry support peptide identity review?

Mass spectrometry supports peptide identity review by helping researchers compare mass-related analytical data against the expected compound record. In Oxytocin documentation review, mass spectrometry is most useful when paired with batch-specific records, LC-MS data, lot traceability, and supplier documentation. It should be treated as part of compound characterization, not as a standalone claim.

Why does research documentation matter for Oxytocin materials?

Research documentation matters because it connects the product listing to the batch-specific file. A stronger documentation set includes the COA, lot number, identity testing, purity review, storage notes, and supplier documentation. These records help qualified researchers evaluate consistency before procurement without relying on broad or claim-heavy language.

How should researchers interpret Oxytocin literature?

Published findings provide context for the specific materials, methods, and models studied. They do not establish the safety, efficacy, or suitability of a supplied research material for non-research use.

---

Researchers Cited in This Guide

The researchers listed below are cited for relevant published work. Their inclusion does not imply that they wrote, reviewed, or endorsed this guide or Pure Lab Peptides products.

Inga D. Neumann

Author profile: Google Scholar

Inga D. Neumann is a scientific author whose published work is closely connected to Oxytocin, neuropeptide research, receptor pathway research, and literature interpretation. Her publications are especially relevant to the article’s discussion of Oxytocin as a peptide hormone, the oxytocin receptor system, and model-specific signaling literature. The publications highlighted below are useful background for understanding Oxytocin receptor signaling and neuropeptide research models.

Selected publications:

• A review of oxytocin receptor signaling pathways — Physiological Reviews, 2018. PMID: [29897293]
• A publication reviewing brain Oxytocin research models — Molecular Psychiatry, 2021. PMID: [32514104]

Valery Grinevich

Author profile: Central Institute of Mental Health Profile

Valery Grinevich is a published researcher whose work is relevant to Oxytocin pathway mapping, neuropeptide research, central signaling models, and receptor-focused literature. His selected publications below provide context for pathway-focused Oxytocin research and broader neuropeptide signaling interpretation.

Selected publications:

• Assembling the Puzzle: Pathways of Oxytocin Signaling in the Brain — Biological Psychiatry, 2016. PMID: [26001309]
• The multiple faces of the oxytocin and vasopressin systems in the brain — Journal of Neuroendocrinology, 2021. PMID: [34218479]

REFERENCES

1. IUPHAR/BPS Guide to Pharmacology. Oxytocin ligand record. IUPHAR/BPS Guide to Pharmacology Database. Accessed 2026.
2. European Bioinformatics Institute. OXYTOCIN compound record, CHEMBL395429. ChEMBL. Accessed 2026.
3. IUPHAR/BPS Guide to Pharmacology. OT receptor record. IUPHAR/BPS Guide to Pharmacology Database. Accessed 2026.
4. UniProt Consortium. Oxytocin receptor, UniProtKB P30559. UniProtKB. Accessed 2026.
5. National Center for Biotechnology Information. OXT gene record. NCBI Gene. Accessed 2026.
6. National Center for Biotechnology Information. OXTR gene record. NCBI Gene. Accessed 2026.
7. International Council for Harmonisation. Q2(R2) Validation of Analytical Procedures. ICH. 2023.
8. U.S. Food and Drug Administration. Analytical procedure validation guidance. FDA Guidance. 2015; updated FDA page accessed 2026.
9. Electronic Code of Federal Regulations. 21 CFR Part 809 laboratory research labeling provision. eCFR. Accessed 2026.
10. U.S. Food and Drug Administration. Research-use-only and investigational-use-only labeling guidance. FDA Guidance. 2013; FDA page accessed 2026.
11. Gimpl G, Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiological Reviews. 2001. PMID: 11274341.
12. Lee HJ, Macbeth AH, Pagani JH, Young WS. Oxytocin: the great facilitator of life. Progress in Neurobiology. 2009. DOI: 10.1016/j.pneurobio.2009.04.001. PMID: 19482229.
13. Russo AF. Overview of neuropeptides: awakening the senses?. Headache. 2017. PMID: 28485842.
14. Mitre M, Minder J, Morina EX, Chao MV, Froemke RC. Oxytocin modulation of neural circuits. Current Topics in Behavioral Neurosciences. 2018. PMID: 28864972.
15. Busnelli M, Chini B. Molecular basis of oxytocin receptor signaling in the brain. Current Topics in Behavioral Neurosciences. 2018. DOI: 10.1007/7854_2017_6. PMID: 28812263.
16. Jurek B, Neumann ID. The oxytocin receptor: from intracellular signaling to behavior. Physiological Reviews. 2018. DOI: 10.1152/physrev.00031.2017. PMID: 29897293.
17. Grinevich V, et al. Oxytocin and sensory-system research review. Neuron. 2018. PMID: 30189208.
18. Chatterjee O, Patil K, Sahu A, et al. An overview of the oxytocin–oxytocin receptor signaling network. Journal of Cell Communication and Signaling. 2016. DOI: 10.1007/s12079-016-0353-7. PMID: 27624619.
19. Willets JM, Brighton PJ, Windell LN, Rana S, Nash CA, Konje JC, et al. Oxytocin receptor responsiveness in cellular signaling models. Molecular Endocrinology. 2009.
20. Mant CT, Hodges RS. HPLC analysis and purification of peptides. Methods in Molecular Biology. 2007.
21. Karpievitch YV, Polpitiya AD, Anderson GA, Smith RD, Dabney AR. Liquid chromatography mass spectrometry-based proteomics. Annals of Applied Statistics. 2010.
22. Florea T, Caughey E, et al. Oxytocin research review of structure, distribution, genetics, and receptor-system context. Frontiers in Endocrinology. 2022.
23. National Institute of Standards and Technology. NIST policy on metrological traceability. NIST. Accessed 2026.
24. United States Pharmacopeia. USP General Chapter 621 Chromatography. USP. 2021.
25. Zeng K, et al. LC-HRMS method for peptide characterization and impurity profiling. AAPS Journal. 2015.
26. Hollebrands B, et al. LC-MS identification of short homologous peptides. Analytical and Bioanalytical Chemistry. 2023.
27. International Council for Harmonisation. Q14 Analytical Procedure Development. ICH. 2023.
28. International Organization for Standardization. ISO/IEC 17025 testing and calibration laboratories. ISO. Accessed 2026.

---

Research Disclaimer

This material is supplied strictly for in vitro laboratory research and is not for human or veterinary use. Published studies describe specific experimental materials, models, and methods; they do not establish the safety, efficacy, or suitability of this catalog product for non-research use. Review the original publications and the lot-specific analytical documentation independently.